Investigación / Publicaciones / Neuro Oncología
PUBLICACIONES NEURO ONCOLOGÍA
Syro LV, Rotondo F, Camargo M, Ortiz LD, Serna CA, Kovacs K J Neurooncol. 2018;136(2):363-371. doi: 10.1007/s11060-017-2660-0 2018
Syro LV, Rotondo F, Camargo M, Ortiz LD, Serna CA, Kovacs K : Endocrinol, 2018. doi.org/10.3389/fendo.2018.00318 2018
(+) Citometría de flujo en reticulocitos de sangre periférica como indicador de inestabilidad cromosómica en pacientes con gliomas de alto grado. Lina Marcela Barrera, León Darío Ortiz, Hugo Grisales, Mauricio Rojas, Mauricio Camargo. Biomédica 2018
Sergio Loaiza, Sonia Carvajal, Daniel Giraldo, Astrid Galvis, León Ortiz.
(+) Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary Luis Syro, Fabio Rotondo, Carlos Serna, León Ortiz, Kalman Kovacs. Pituitary 2016
Genotyping low-grade gliomas among Hispanics
Andrés Cardona, Leonardo Rojas, Beatriz Wills, José Behaine, Enrique Jiménez, León Darío Ortiz.
(+) Autophagy in the endocrine glands Andrea Weckman, Antonio Di Ieva, Fabio Rotondo, Luis V Syro, Leon D Ortiz, Kalman Kovacs and Michael D Cusimano. Journal of Molecular Endocrinology 2014
(+) Complejo esclerosis tuberosa Carlos Medina Malo, Orlando Carreño, Alberto Vélez, Luis Arturo Lizcano, León Darío Ortiz, Henry Becerra, Andrés Felipe Cardona. Acta Neurológica Colombiana 2012
(+) Anti-VEGF therapy in pituitary carcinoma Leon D. Ortiz, Luis V. Syro, Bernd W. Scheithauer, Ayca Ersen, Humberto Uribe, Camilo E. Fadul, Fabio Rotondo, Eva Horvath, Kalman Kovacs Pituitary 2012
(+) Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy. Olga Moshkin, Luis V. Syro, Bernd W. Scheithauer, Leon D. Ortiz, Camilo E. Fadul, Humberto Uribe, Ricardo Gonzalez, Michael Cusimano, Eva Horvath, Fabio Rotondo, Kalman Kovacs Hormones 2011
(+) Undifferentiated Sarcoma of the Sellar Region Branavan Manoranjan, Luis V. Syro, Bernd W. Scheithauer, León Darío Ortiz, Eva Horvath, Fateme Salehi, Kalman Kovacs, Michael D. Cusimano. Endocrine Pathology 2011
Aggressive Silent Subtype 2 Pituitary Corticotroph Adenoma Progressing to Carcinoma and Treated with Temozolomide Olga Moshkin, Luis V. Syro, Bernd W. Scheithauer, Leon D. Ortiz, Camilo E. Fadul, Humberto Uribe, Ricardo Gonzalez, Michael Cusimano, Eva Horvath, Fabio Rotondo, Kalman Kovacs. Case Report 2010
(+) Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma Luis V. Syro, Bernd W. Scheithauer, Leon D. Ortiz, Camilo E. Fadul, Eva Horvath, Fabio Rotondo, Kalman Kovacs. Hormones 2009
(+) MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy Kalman Kovacs, Bernd W. Scheithauer, Matilde Lombardero, Roger E. McLendon,	Luis V. Syro, Humberto Uribe, Leon D. Ortiz, Luis C. Penagos Acta Neuropathol 2008
(+) Erratum to bTemozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings. Kalman Kovacs, Eva Horvath, Luis V. Syro, Humberto Uribe, Luis C. Penagros, Leon D. Ortiz, Camilo E. Fadul. Human Pathology 2007
(+) Temozolomide therapy in a man with an aggressive	prolactin-secreting pituitary neoplasm:	morphological findings Kalman Kovacs, Eva Horvath, Luis V. Syro, Humberto Uribe, Luis C. Penagros, Leon D. Ortiz, Camilo E. Fadul. Human Pathology 2007
Análisis de la codeleción 1p19q como marcador pronóstico en pacientes con glioblastoma primario. Andrés Felipe Cardona, León Darío Ortiz, Henry Becerra, Enrique Jimenez-Hakim5, Fernando Hakim, Juan Armando Mejía, Sonia Bermúdez, Nicolás Useche, Carlos Emilio Restrepo, Silvia Serrano, Hernán Carranza, Carlos Vargas, Jorge Miguel Otero, Álvaro Muñoz, Pilar Archila, Orlando Ricaurte, Ludovic Reveiz, July Katherine Rodríguez, Andrés Acevedo, Germán Pena, Diana Torres. Colombiana de Hematología y Oncología